Compare Edwards Lifesciences Corporation Common Stock (EW) vs Direxion Daily S&P 500 Bull 3X Shares (SPXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Direxion Daily S&P 500 Bull 3X Shares — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Direxion Daily S&P 500 Bull 3X Shares trades at $296.95 (market cap $7.42B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 6.7× Direxion Daily S&P 500 Bull 3X Shares's market cap, and Direxion Daily S&P 500 Bull 3X Shares is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | SPXL | |
|---|---|---|
Market Cap | $49.44B | $7.42B |
Volume | 3,508,027 | 1,583,684 |
Sector | Health | Leveraged / Inverse |
52-Week High | $95.18 | $301.38 |
52-Week Low | $72.65 | $170.20 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 32 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPXL, a leveraged ETF tracking the S&P 500, trades at $296.84, down 0.79% on the day. Technical indicators show a bullish trend with strong moving average support, though RSI levels suggest potential near-term overbought conditions. The ETF reflects broader market dynamics with support at $294 and resistance at $299. Recent news highlights mixed S&P 500 sentiment, with strong 2026 earnings growth expectations but concerns about 2027 slowdowns and market concentration risks.
The outlook remains cautiously optimistic given the bullish technical setup and strong corporate earnings, though risks include potential profit growth deceleration and geopolitical volatility. Institutional sentiment appears balanced between seasonal rally expectations and valuation concerns, requiring careful monitoring of economic indicators and Fed policy for directional clarity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Direxion Daily S&P 500 Bull 3X Shares
SPXL aims for 300% of the S&P 500's daily performance. It uses swaps and futures to provide 3x leverage, making it a high-risk tool for short-term traders. Due to daily resets, it is prone to volatility decay and is not intended for long-term holding.
Read more on SPXL →
